DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 171 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $256,446 | -7.4% | 16,303 | -5.0% | 0.00% | – |
| Q4 2023 | $276,920 | +19.2% | 17,168 | -6.0% | 0.00% | – |
| Q3 2023 | $232,343 | -0.4% | 18,266 | +10.3% | 0.00% | – |
| Q2 2023 | $233,263 | -3.1% | 16,567 | +6.3% | 0.00% | – |
| Q1 2023 | $240,773 | +4.6% | 15,584 | +11.0% | 0.00% | – |
| Q4 2022 | $230,181 | +4.2% | 14,044 | +17.3% | 0.00% | – |
| Q3 2022 | $221,000 | +64.9% | 11,968 | +16.8% | 0.00% | – |
| Q2 2022 | $134,000 | -79.3% | 10,250 | -46.2% | 0.00% | – |
| Q3 2021 | $648,000 | -8.5% | 19,056 | -1.5% | 0.00% | – |
| Q2 2021 | $708,000 | -24.4% | 19,353 | -7.3% | 0.00% | -100.0% |
| Q1 2021 | $937,000 | -22.9% | 20,877 | -2.1% | 0.00% | 0.0% |
| Q4 2020 | $1,216,000 | +43.7% | 21,315 | +29.2% | 0.00% | 0.0% |
| Q3 2020 | $846,000 | -17.8% | 16,495 | -4.3% | 0.00% | 0.0% |
| Q2 2020 | $1,029,000 | +229.8% | 17,235 | +127.7% | 0.00% | – |
| Q1 2020 | $312,000 | -29.9% | 7,568 | +5.7% | 0.00% | – |
| Q4 2019 | $445,000 | – | 7,157 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $19,824,869 | 14.35% |
| Redmile Group, LLC | 3,593,317 | $58,894,466 | 2.41% |
| BRAIDWELL LP | 3,271,513 | $53,620,098 | 1.80% |
| Parkman Healthcare Partners LLC | 344,920 | $5,653,239 | 1.50% |
| ARMISTICE CAPITAL, LLC | 5,172,000 | $84,769,080 | 1.48% |
| Ikarian Capital, LLC | 367,119 | $6,017,081 | 1.45% |
| Sunesis Advisors, LLC | 96,299 | $1,578,341 | 1.01% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,349,228 | $38,503,847 | 0.80% |
| Hillsdale Investment Management Inc. | 328,200 | $5,379,198 | 0.46% |
| Avidity Partners Management LP | 1,126,000 | $18,455,140 | 0.40% |